Hot News: Clovis Oncology (NASDAQ:CLVS), Nokia Corporation (ADR) (NYSE:NOK), Key Technology (NASDAQ:KTEC), The First Bancorp (NASDAQ:FNLC), Capital One Financial (NYSE:COF)

Leerink Swann initiated coverage on shares of Clovis Oncology (NASDAQ:CLVS) in a research report released on Friday morning. The firm issued an outperform rating and a $100.00 price objective on the stock. Clovis Oncology, Inc. (NASDAQ:CLVS) belongs to Healthcare sector. Its weekly performance is 11.49%. On last trading day company shares ended up $48.61. Clovis Oncology, Inc. (NASDAQ:CLVS) distance from 50-day simple moving average (SMA50) is 20.42%. … Continue reading Hot News: Clovis Oncology (NASDAQ:CLVS), Nokia Corporation (ADR) (NYSE:NOK), Key Technology (NASDAQ:KTEC), The First Bancorp (NASDAQ:FNLC), Capital One Financial (NYSE:COF)

Stocks to Watch: Arch Coal Inc (NYSE:ACI), Clovis Oncology (NASDAQ:CLVS), 8×8 (NASDAQ:EGHT), Pier 1 Imports (NYSE:PIR), Jive Software Inc (NASDAQ:JIVE)

Arch Coal Inc. (NYSE:ACI) need to fix it all to protect shareholder value and its falling share prices. The Company won top Colorado awards during last month for its environmental friendly measures as well as workplace safety. However, the recent Environmental Protection Agency’s proposal to reduce carbon emission by cutting coal use and recent accusations of kickbacks taken by Arch Coal workers are potentially driving … Continue reading Stocks to Watch: Arch Coal Inc (NYSE:ACI), Clovis Oncology (NASDAQ:CLVS), 8×8 (NASDAQ:EGHT), Pier 1 Imports (NYSE:PIR), Jive Software Inc (NASDAQ:JIVE)

Aastrom Biosciences Inc (NASDAQ:ASTM) posted its quarterly earnings results on Thursday. The company reported ($1.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by $0.34, AnalystRatings.NET reports. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of the company in a research note on Friday, March 14th. They now have a $5.00 price target on the … Continue reading Biotech Volatile Stocks: Aastrom Biosciences Inc (NASDAQ:ASTM), Puma Biotechnology Inc (NYSE:PBYI), Oncolytics Biotech (NASDAQ:ONCY), Clovis Oncology (NASDAQ:CLVS), Idenix Pharmaceuticals (NASDAQ:IDIX)